NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
12,954,107
Share change
-85,018
Total reported value
$4,661,000
Price per share
$0.36
Number of holders
48
Value change
-$33,133
Number of buys
13
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q1 2018

As of 31 Mar 2018, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,954,107 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Harel Insurance Investments & Financial Services Ltd., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, JACOBS LEVY EQUITY MANAGEMENT, INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, NORTHERN TRUST CORP, Bank of New York Mellon Corp, and WEDBUSH SECURITIES INC. This page lists 48 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.